• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK JUVEDERM VOLUMA-ADDITIVE
Device Problem Off-Label Use (1494)
Patient Problem Angioedema (4536)
Event Date 02/09/2021
Event Type  Injury  
Manufacturer Narrative
Article citation: munavalli, girish gilly, et al.¿covid-19/sars-cov-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment.¿ archives of dermatological research, 09 feb 2021.Crossref, doi:10.1007/s00403-021-02190-6.Allergan is unable to gather additional event, product, or patient details as contact information was not provided in the article.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.This is a known potential adverse event addressed in the product labeling.This is the same article reported under mdr id# 3005113652-2021-00161 allergan complaint # (b)(4) and mdr id# 3005113652-2021-00160 allergan complaint # (b)(4).
 
Event Description
Journal article ¿covid-19/sars- cov-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment¿ reported a patient case 3 experienced ¿generalized myalgias and fever of 101.6 f more than one year post injection into the bilateral tear troughs with juvederm voluma and into the upper and lower lip with juvéderm ultra and 12 hours after vaccination for covid-19 with moderna vaccine.500mg of acetaminophen was taken for symptom management with resolution of fever the following morning.The patient then experienced increased tenderness in the right tear trough, throughout the day, the unilateral infraorbital edema worsened and perioral edema began to develop.36h post vaccination, 10mg of certirizine was administered.The patient reported 48h post vaccination infraorbital swelling and perioral angioedema was at its peak and she was unable to open the right eye and throughout the morning, the left tear trough swelling subjectively increased, while the rest of the face remained persistently swollen, in areas of previous filler injection¿.The patient declined corticosteroids and was treated with oral lisinopril.This is the same event and the same patient reported under mdr id# 3005113652-2021-00164 allergan complaint # (b)(4).This mdr is being submitted for the suspect product, juvederm voluma.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN)
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 
7372473605
MDR Report Key11457751
MDR Text Key243148707
Report Number3005113652-2021-00163
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK JUVEDERM VOLUMA-ADDITIVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age36 YR
-
-